scispace - formally typeset
L

Liankang Sun

Researcher at Xi'an Jiaotong University

Publications -  25
Citations -  970

Liankang Sun is an academic researcher from Xi'an Jiaotong University. The author has contributed to research in topics: Pancreatic cancer & Cancer stem cell. The author has an hindex of 14, co-authored 25 publications receiving 602 citations.

Papers
More filters
Journal ArticleDOI

Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer.

TL;DR: Metformin inhibited pancreatic cancer initiation, suppressed chronic pancreatitis-induced tumorigenesis, and showed promising therapeutic effect in PDAC.
Journal ArticleDOI

Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1.

TL;DR: The mechanism by which resveratrol enhanced chemosensitivity and the role of sterol regulatory element binding protein 1 (SREBP1) in gemcitabine‐induced stemness are explored.
Journal ArticleDOI

Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways

TL;DR: It is demonstrated that resveratrol suppresses the expression of NAF-1 in pancreatic cancer cells by inducing cellular reactive oxygen species (ROS) accumulation and activating Nrf2 signaling, which can improve the sensitivity of pancreaticcancer cells to gemcitabine.
Journal ArticleDOI

Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF1-dependent pathway.

TL;DR: A novel mechanism by which the loss of AMPK activation amplifies the activity of HSF1 to promote the invasion and metastasis of pancreatic cancer is revealed.